/PRNewswire/ Theravance Biopharma, Inc. ("Theravance" or the "Company") (NASDAQ: TBPH) today announced the appointment to its Board of Directors of Jeremy.
Theravance Biopharma, Inc. ("Theravance" or the "Company") today announced the appointment to its Board of Directors of Jeremy Grant, who serves as a Special Advisor to Irenic Capital Management LP ("Irenic"). With the addition of Mr. Grant,.
Enters into Cooperation Agreement with Shareholder Irenic Capital
Reaffirms Intention to Return All Excess Capital to Shareholders and MaximizeShareholder Value
DUBLIN, Dec. 21, 2023 /PRNewswire/ .
Security experts testified to Congress ahead of a looming 2025 deadline for national compliance that the National Institute of Standards and Technology is better